Christopher Darling Email & Phone Number

New York, New York, United States

DermaClip is a non-invasive skin closure device that allows for the quick and easy closure of surface wounds and the final stage of surgical incisions with no puncturing or crushing of the skin. The patented non-invasive design of DermaClip is intended to evert the skin on every closure to promote healthy healing and is quick and easy-to-use. The device targets a new standard of wound closure, aiming to enhance ease of use and patient experience. Put simply, the goal of the DermaClip is to eliminate trade-offs in skin closure between time of closure and quality of patient care.The device is a single-use, non-invasive, needle-less skin closure device that is designed to achieve full eversion on each skin closure. This is accomplished through a patented design that incorporates a plastic structures that mates a "Living Hinge"​ sandwiched between two layers of alkylate-based, non-latex adhesive to a ratchet mechanism so as to lift the skin in the closure process and evert it.

New York, New York, United States

DermaQuik brings the hospital proven technology of DermaClip (an Rx device) to an over-the-counter skin closure device that can be closed with one hand in any environment. The main benefits of DermaQuik over the competition:• Completely non-invasive, no needles / micro-needles or punctures;• Creates skin edge eversion on closure, the gold standard of skin closure;• Applies with only one-hand;• No burning at application or drying / curing time;• Can handle wounds with curvature;• Two adhesive options, depending on your use profile;More information can be found on our website, www.DermaQuik.com.

San Francisco Bay Area

MBA intern at a private equity firm with $500 million under management focused on investments in the healthcare sector. • Evaluated investment opportunities in healthcare services and IT subsectors• Conducted structuring, business, and financial due diligence on opportunities in robotics and revenue cycle management; met target management; and prepared Investment Committee memos and bids• Assisted with business development efforts of portfolio companies’ management teams; developing bolt-on acquisition strategy for medical practice expansion; devising capital structure restructuring strategic plans; building leveraged buyout and operating models; and presenting recommendations to Investment Committee / Boards of Directors

London, United Kingdom

• Developed and managed Bank’s client relationships with select European middle-market financial institutions• Coordinated client relationships sell full suite of CIB (Fixed Income, Equities, Structured & Trade Finance) and Securities Services products

Brussels Area, Belgium

• Key responsibility for strategic development and rollout of IBG, a group with an initial team of 30 bankers, managing 600 clients worldwide, and EUR 100 million of incremental revenues• Implementation included building support for the new group with Group Management, Heads of Investment Banking / Fixed Income / Equities, other key stakeholders and top clients• Supported Global Head of IBG manage group's strategic clients in Europe and Asia• Represented the Bank at the 2009 and 2010 IMF Conferences in Istanbul and Washington, DC• Conducted hiring process for initial 30 IBG bankers in 16 countries

Brussels Area, Belgium

• During bank's liquidity crisis in 4Q 2008, assisted initiative stabilizing Fortis Bank liquidity position post-collapse and during Belgian State intervention• Worked on strategic planning and business development under Global Head of FIG• Led team managing possible enactment of Belgian State guarantee and transition post-BNP Paribas acquisition• Co-authored white paper to create the Institutional Banking Group as part of Fortis’ integration into BNP Paribas

Greater New York City Area

Rotational program with associates completing up to 5 rotations in the course of 15 months. • Completed rotations in Private Equity Fund of Funds, Corporate Finance / Capital Markets (“CF/CM”), FIG Americas, and FIG Europe (in Brussels)• Assisted PE Fund of Funds group in managing $1 billion private equity portfolio, participated in due diligence for $37.5 million in placements and led a $10 million investment in distressed debt fund• Conducted diligence on $7.5 billion of Equity & Debt deals for CF/CM group, generating $5.5 million in revenues• Helped 6 person FIG Americas team manage $7 billion lending portfolio and conducted client / transaction due diligence

Greater New York City Area

Consultant in Organization & Change group in the Human Capital practice.• Industry focus on Financial Services• Project range included post-merger integration, organization design, performance management and outsourcing, working with firm and client leaders to develop solutions related to people and strategy• Conducted strategy sessions, developed deliverables, managed client staff / third party vendors, grew new / existing client relationships and assisted in sales efforts / methodology development

Master Of Business Administration (Mba), Finance, General

Bachelor Of Arts (B.A.), Economics

Double major in Economics and International Relations (focus on China) • Boston University London Study Abroad & Internship Program (Sep.